Cargando…
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients
This study evaluated the safety and feasibility of transendocardial injections of VentriGel, a cardiac extracellular matrix hydrogel, in early and late post–myocardial infarction (MI) patients with left ventricular (LV) dysfunction. VentriGel was delivered in 15 patients with moderate LV dysfunction...
Autores principales: | Traverse, Jay H., Henry, Timothy D., Dib, Nabil, Patel, Amit N., Pepine, Carl, Schaer, Gary L., DeQuach, Jessica A., Kinsey, Adam M., Chamberlin, Paul, Christman, Karen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834965/ https://www.ncbi.nlm.nih.gov/pubmed/31709316 http://dx.doi.org/10.1016/j.jacbts.2019.07.012 |
Ejemplares similares
-
Simple and High Yielding Method for Preparing Tissue Specific Extracellular Matrix Coatings for Cell Culture
por: DeQuach, Jessica A., et al.
Publicado: (2010) -
Extracellular Matrix Biomaterial Therapy for Myocardial Infarction: New Delivery Route and Immunomodulatory Effects
por: Christman, Karen L.
Publicado: (2023) -
Injectable Myocardial Matrix Hydrogel Mitigates Negative Left Ventricular Remodeling in a Chronic Myocardial Infarction Model
por: Diaz, Miranda D., et al.
Publicado: (2021) -
Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model
por: Ungerleider, Jessica L., et al.
Publicado: (2016) -
Hydrogels as Extracellular Matrix Analogs
por: González-Díaz, Eva C., et al.
Publicado: (2016)